Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024;16(22):2321-2323.
doi: 10.4155/fmc-2019-0174. Epub 2024 May 29.

Epigenetics: rethinking of drug research and development

Kenneth Lundstrom  1
Affiliations
Editorial

Epigenetics: rethinking of drug research and development

Kenneth Lundstrom. Future Med Chem. 2024.
No abstract available

Keywords: biotechnology; drug development; drug discovery; epigenetics; infectious disease therapeutics; molecular biology; neurological therapeutics; oncological therapeutics.

PubMed Disclaimer

Conflict of interest statement

The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

References

    1. Lundstrom K. Epigenetics, nutrition, disease and drug development. Curr. Drug Discov. Technol. doi:10.2174/1570163815666180419154954 [Epub ahead of print] (2018). - DOI - PubMed
    1. Su LJ, Mahabir S, Ellison GL, McGuinn LA, Reid BC. Epigenetic contributions to the relationship between cancer and dietary intake of nutrients, bioactive food components and environmental toxicants. Front Genet. 2,91 (2012). - PMC - PubMed
    1. Lundstrom K. MicroRNA in disease and gene therapy. Curr. Drug Discov. Technol. 8(2), 76–86 (2011). - PubMed
    1. Park H, Chung H, Lee Jet al. . Decitabine as a first-line treatment for older adults newly diagnosed with acute myeloid leukemia. Yonsei Med. J. 58(1), 35–42 (2017). - PMC - PubMed
    1. Kaminskas E, Farrell AT, Wang Y-Cet al. . FDA drug approval summary: azacitidine (5-azacytidine, Vidaza™) for injectable suspension. Oncologist 10(3), 176–182 (2005). - PubMed

Publication types

LinkOut - more resources